
Rosen Investor Counsel Gives Thumbs Up to Neumora Therapeutics: A Trusted Advisor’s Perspective
Heads Up, Neumora Therapeutics Investors: Important Deadline Approaching In the bustling world of finance, where initial public offerings (IPOs) are as common as a New York City hot dog stand, it’s easy to get swept up in the excitement of buying into a new company. But what happens when things don’t go as planned? That’s…